New drug AV-001 aims to help hospitalized pneumonia patients breathe easier

NCT ID NCT05123755

First seen Feb 28, 2026 · Last updated May 12, 2026 · Updated 5 times

Summary

This study tests an experimental drug called AV-001 in 120 hospitalized adults with pneumonia who need extra oxygen. The drug is given daily through an IV and compared to a placebo, alongside standard care. The goal is to see if AV-001 is safe and helps patients recover faster from pneumonia caused by COVID-19 or other respiratory infections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Denver Health Medical Center

    RECRUITING

    Denver, Colorado, 80203, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Henry Ford Health System

    RECRUITING

    Detroit, Michigan, 48202, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hoag Memorial Hospital Presbyterian

    RECRUITING

    Newport Beach, California, 92658-6100, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • MedStar Health Research Institute, Inc.

    RECRUITING

    Hyattsville, Maryland, 20782, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Ohio State University

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.